Phillip O Coffin

Summary

Publications

  1. ncbi Patient acceptance of universal screening for hepatitis C virus infection
    Phillip O Coffin
    Division of Allergy and Infectious Diseases, University of Washington, Seattle WA, USA
    BMC Infect Dis 11:160. 2011
  2. ncbi Prevalence and characteristics of femoral injection among Seattle-area injection drug users
    Phillip O Coffin
    Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA
    J Urban Health 89:365-72. 2012
  3. ncbi Cost-effectiveness and population outcomes of general population screening for hepatitis C
    Phillip O Coffin
    Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98104, USA
    Clin Infect Dis 54:1259-71. 2012

Collaborators

Detail Information

Publications3

  1. ncbi Patient acceptance of universal screening for hepatitis C virus infection
    Phillip O Coffin
    Division of Allergy and Infectious Diseases, University of Washington, Seattle WA, USA
    BMC Infect Dis 11:160. 2011
    ..Although universal screening might be a cost-effective way to identify infections, prevent morbidity, and reduce transmission, few efforts have been made to determine patient opinions about new approaches to screening...
  2. ncbi Prevalence and characteristics of femoral injection among Seattle-area injection drug users
    Phillip O Coffin
    Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA
    J Urban Health 89:365-72. 2012
    ..Interventions, such as education regarding the hazards of central venous injection and guidance on safe injection into peripheral veins, are needed to minimize the health consequences of femoral injection...
  3. ncbi Cost-effectiveness and population outcomes of general population screening for hepatitis C
    Phillip O Coffin
    Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98104, USA
    Clin Infect Dis 54:1259-71. 2012
    ..Current US guidelines recommend limiting hepatitis C virus (HCV) screening to high-risk individuals, and 50%-75% of infected persons remain unaware of their status...